We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




3D Printed Diagnostic Device Rapidly Detects Anemia

By LabMedica International staff writers
Posted on 07 Mar 2016
A new biomedical device has been developed using 3D printers to create a low cost, point-of-care device that can quickly detect anemia, a condition in which the blood does not have enough healthy red blood cells to transport oxygen to the body's organs. More...


Point-of-care devices give the user fast, easy-to-understand results from a test performed outside of a laboratory, such as a blood glucose test or pregnancy test and identifying a blood disorder may be as easy as running a blood sample from a finger prick under a smartphone.

Scientists at Kansas State University (Olathe, KS, USA) made the device with a Projet 1200 3D printer (3DSystems; Rock Hill, SC, USA) and designed it to detect anemia for individuals who have limited access to health care, such as those living in developing countries. Anemia affects two billion people worldwide, including more than half of preschool children and pregnant women in developing countries and at least 30% of children and women in some industrialized nations.

The device consists of 3D printed clear plastic slides containing microfluidics that attach to a smartphone. The user adds a drop of their blood to a slide, which is used for a color scale-based test. The test results are produced in less than 60 seconds and can be read using a smartphone. A companion app is being developed with Steve Warren, PhD, an associate professor in electrical and computer engineering at Kansas State University, which could manage data from the blood sample and even send the results to a doctor.

Kim Plevniak, a master's student in biological and agricultural engineering, who worked on the device, said, “Anemia is a very prevalent condition in developing countries even though it is easily treated with iron supplements or vitamins and can be prevented with a healthy diet. Often in these developing countries people will have much easier access to smartphones than they will to doctors and trained medical professionals.”

Related Links:

Kansas State University 
3Dsystems



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.